Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 14/20 | 0.53 |
| ▸ | HTR2A | P28223 | 14/20 | 0.53 |
| ▸ | HTR7 | P34969 | 12/20 | 0.53 |
| ▸ | HTR1A | P08908 | 11/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.53 |
| ▸ | DRD3 | P35462 | 9/20 | 0.53 |
| ▸ | HTR2C | P28335 | 6/20 | 0.53 |
| ▸ | DRD1 | P21728 | 2/20 | 0.53 |
| ▸ | HRH1 | P35367 | 5/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 4/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL5198984 | 0.92 | SLC6A4 (0.51) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL5185901 | 0.92 | DRD2 (0.50) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL5187755 | 0.87 | DRD2 (0.49) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL5185969 | 0.82 | DRD2 (0.59) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL5185988 | 0.81 | DRD2 (0.56) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| Hydrochloric Acid SCHEMBL5188377 | 0.81 | DRD2 (0.61) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL5185915 | 0.80 | SLC6A4 (0.64) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL491920 | 0.80 | SMN1; SMN2 (0.60) | — | |
| Hydrochloric Acid SCHEMBL7522315 | 0.79 | SLC6A4 (0.63) | DRD2HTR2AHTR7HTR1ASLC6A4 | |
| SCHEMBL7528236 | 0.79 | DRD2 (0.67) | DRD2HTR2AHTR7HTR1ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1325917-B1 | Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands | JANSSEN PHARMACEUTICA NV (BE) | 2007-01-03 | — | — | EP | disclosed |
| EP-0912533-B1 | ALKYLAMINOBENZOTHIAZOLE AND -BENZOXAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2004-09-29 | — | — | EP | disclosed |
| EP-1325917-A1 | Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-07-09 | — | — | EP | disclosed |
| US-6224849-B1 | Alkylaminobenzothiazole and-benzoxazole derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-05-01 | — | — | US | disclosed |
| US-6103725-A | HIGH AFFINITY TO THE DOPAMINE D4 RECEPTOR; ANTAGONISTS; ANTIPSYCHOTIC AGENTS, E.G. SCHIZOPHRENIA, WITH REDUCED SIDE-EFFECTS; ANTIPSYCHOTIC AGENTS; ANXIOLYTIC AND ANTIEMETIC AGENTS; MOTORIC FUNCTIONS, ADDICTION, SLEEP, FEEDING | JANSSEN PHARMACEUTICA, N.V. (BE) | 2000-08-15 | — | — | US | disclosed |
| EP-0912533-A1 | ALKYLAMINOBENZOTHIAZOLE AND -BENZOXAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-05-06 | — | — | EP | disclosed |
| WO-1997043271-A1 | ALKYLAMINOBENZOTHIAZOLE AND -BENZOXAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-11-20 | — | — | WO | disclosed |